Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients.
ERJ Open Res
; 4(1)2018 Jan.
Article
in En
| MEDLINE
| ID: mdl-29450203
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
ERJ Open Res
Year:
2018
Type:
Article
Affiliation country:
France